McEwan P - Search Results

1

A population model evaluating the costs and benefits associated with different oral treatment strategies in people with type 2 diabetes.

McEwan P, Evans M, Bergenheim K. McEwan P, et al. Diabetes Obes Metab. 2010 Jul;12(7):623-30. doi: 10.1111/j.1463-1326.2010.01198.x. Diabetes Obes Metab. 2010. PMID: 20590737

2

Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.

Evans M, McEwan P, Peters JR, Currie CJ. Evans M, et al. Among authors: mcewan p. Diabetes Obes Metab. 2004 Jul;6(4):299-307. doi: 10.1111/j.1462-8902.2004.00340.x. Diabetes Obes Metab. 2004. PMID: 15171755 Review. No abstract available.

3

The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications.

Currie CJ, Morgan CL, Dixon S, McEwan P, Marchant N, Bearne A, Sharplin P, Peters JR. Currie CJ, et al. Among authors: mcewan p. Diabetes Res Clin Pract. 2005 Feb;67(2):144-51. doi: 10.1016/j.diabres.2004.01.002. Diabetes Res Clin Pract. 2005. PMID: 15649574

4

Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus.

Cockcroft JR, Wilkinson IB, Evans M, McEwan P, Peters JR, Davies S, Scanlon MF, Currie CJ. Cockcroft JR, et al. Among authors: mcewan p. Am J Hypertens. 2005 Nov;18(11):1463-7; discussion 1468-9. doi: 10.1016/j.amjhyper.2005.05.009. Am J Hypertens. 2005. PMID: 16280282

5

Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster).

McEwan P, Peters JR, Bergenheim K, Currie CJ. McEwan P, et al. Curr Med Res Opin. 2006 Jan;22(1):121-9. doi: 10.1185/030079906X80350. Curr Med Res Opin. 2006. PMID: 16393438

6

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

Currie CJ, Morgan CL, Poole CD, Sharplin P, Lammert M, McEwan P. Currie CJ, et al. Among authors: mcewan p. Curr Med Res Opin. 2006 Aug;22(8):1523-34. doi: 10.1185/030079906X115757. Curr Med Res Opin. 2006. PMID: 16870077

7

Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United Kingdom.

Woehl A, Evans M, Tetlow AP, McEwan P. Woehl A, et al. Among authors: mcewan p. Cardiovasc Diabetol. 2008 Aug 11;7:24. doi: 10.1186/1475-2840-7-24. Cardiovasc Diabetol. 2008. PMID: 18694484 Free PMC article.

8

Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model.

McEwan P, Evans M, Kan H, Bergenheim K. McEwan P, et al. Diabetes Obes Metab. 2010 May;12(5):431-6. doi: 10.1111/j.1463-1326.2009.01184.x. Diabetes Obes Metab. 2010. PMID: 20415691

9

Assessing the relationship between computational speed and precision: a case study comparing an interpreted versus compiled programming language using a stochastic simulation model in diabetes care.

McEwan P, Bergenheim K, Yuan Y, Tetlow AP, Gordon JP. McEwan P, et al. Pharmacoeconomics. 2010;28(8):665-74. doi: 10.2165/11535350-000000000-00000. Pharmacoeconomics. 2010. PMID: 20524723

10

Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden.

Granström O, Bergenheim K, McEwan P, Sennfält K, Henriksson M. Granström O, et al. Among authors: mcewan p. Prim Care Diabetes. 2012 Jul;6(2):127-36. doi: 10.1016/j.pcd.2011.09.003. Epub 2011 Oct 15. Prim Care Diabetes. 2012. PMID: 22001114 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters